11 completed, 7 unknown, 2 active not recruiting. 11 Phase 3, 4 Phase 4, 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 8, Unknown 2, Active not recruiting 1 |
| Phase 4 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 3 | Unknown 2, Active not recruiting 1 |
| Phase 1 | 2 | Unknown 2 |
Follow Taejoon Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of TJO-087 TJO-087, Vehicle (Placebo solution) - Dry Eye Syndrome (DES) | Phase 2 | Active not recruiting | Taejoon Pharmaceutical Co., Ltd. | 90 | 2026-04-06 | 2026-09-09 |
| Evaluate the Efficacy and Safety of CTO0308 in Pediatric Patients With Myopia CTO0308, Vehicle (Placebo solution) - Myopia | Phase 3 | Active not recruiting | Taejoon Pharmaceutical Co., Ltd. | 351 | 2025-08-11 | 2026-09-01 |
| Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia CTO0307 Eye drop, Vehicle (Placebo solution) - Presbyopia | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 167 | 2025-02-26 | 2026-08-28 |
| Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects CTO0303-A, CTO0303-B, CTO0303-C - Pupillary Dilation Effect During Cycloplegic Refraction | Phase 2 / Phase 3 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 156 | 2024-05-09 | 2024-09-24 |
| Chest CT Using Low-concentration Iodine Contrast Media Iohexol (320mgI/mL) with 120kVp, Iohexol (320mgI/mL) with 100kVp, Iohexol (270mgI/mL) with 100kVp - Pulmonary Disease | Phase 4 | Unknown | Jung Im Jung | 370 | 2023-11-24 | 2024-07-25 |
| A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy CTP0302-A, CTP0302-B, Conventional OST - Bowel Preparation | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 161 | 2023-08-29 | 2024-11-29 |
| Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients TJO-083, Diquafosol ophthalmic sodium solution 3% - Dry Eye, Dry Eye Syndromes | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 271 | 2023-07-14 | 2025-04-22 |
| A Phase 3 Trial in Bowel Preparation for Colonoscopy CTP0301-A, CTP0301-B, Cool prep - Bowel Preparation | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 137 | 2023-01-30 | 2024-02-28 |
| A Study on the Verification of Kidney CT Non-inferiority Using Low Concentration Contrast Agent Contrast enhanced Kidney CT - Renal Disease | Unknown | Seoul National University Hospital | 88 | 2023-01-20 | 2023-04-26 | |
| A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial CTP0303, Orafang Tab - Bowel Preparation | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 84 | 2022-09-21 | 2023-03-01 |
| Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease Fluorometholone 0.1% ophthalmic solution, Cyclosporine 0.05% eye drops - Dry Eye Disease (DED) | Phase 4 | Completed | Korea University Anam Hospital | 32 | 2022-09-01 | 2025-03-14 |
| Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients TJO-083, Placebo (vehicle), Diquafosol ophthalmic sodium solution 3% - Dry Eye Syndromes | Phase 1 / Phase 2 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 98 | 2021-10-14 | 2022-04-26 |
| A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults CTO0101, Placebo (vehicle) - Healthy | Phase 1 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 16 | 2021-10-05 | 2022-03-02 |
| Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients TJO-087, Cyclosporine ophthalmic solution 0.05% - Dry Eye Syndrome | Phase 3 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 182 | 2020-06-19 | 2022-02-18 |
| Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients TJO-018 (HA 0.15%), Cyclosporine Ophthalmic Emulsion 0.05% standard therapy (CMC 0.5% add), TJO-018 (HA 0.15%) + Cyclosporine Ophthalmic Emulsion 0.05% - Dry Eye, Dry Eye Syndromes | Phase 4 | Completed | Taejoon Pharmaceutical Co., Ltd. | 438 | 2019-11-12 | 2022-06-08 |
| Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. Xalost S, Xalatan, Taflotan-S - Glaucoma | Phase 4 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 144 | 2018-12-19 | 2019-11-15 |
| A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy TJP-008-1, TJP-008-2, Coolprep powder - Bowel Preparation | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 297 | 2018-01-02 | 2019-09-04 |
| A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients TJO-002, Latanoprost - Primary Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 146 | 2016-04-26 | 2019-09-04 |
| A Study of HCC High Risk Group Using Two Surveillance Tools non-ionic monomer iodinated CT contrast media - HCC | Completed | Seoul National University Hospital | 139 | 2014-11-28 | 2020-10-08 | |
| Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes CYPORIN N EYE DROPS 0.05%(TJCS eye drop), Restasis - Dry Eye Syndromes | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 158 | 2014-01-01 | 2015-06-03 |
Dry Eye Syndromes (7) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Kidney Diseases (1) · Lung Diseases (1) · Mydriasis (1) · Myopia (1) · Ocular Hypertension (1) · Presbyopia (1)
Cyclosporins (2) · Latanoprost (2) · Control Groups (1) · Cyclosporine (1) · Fluorometholone (1) · Iohexol (1) · MCC protocol (1) · Ophthalmic Solutions (1) · Standard of Care (1) · polyethylene glycol 3350 (1)
South Korea (20)
Hyo Myung Kim, MD, PhD (1) · Hyung Keun Lee, MD (1) · Jae Myung Cha, MD, PhD (1) · Jaemyung Cha, MD. PhD (1) · Jeong Min Lee, MD (1) · June Young Seo, MD (1) · Jung Im Jung, MD, PhD (1)